Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma. [electronic resource]
Producer: 20070928Description: 502-5 p. digitalISSN:- 0007-1048
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Diphtheria Toxin -- therapeutic use
- Female
- Humans
- Interleukin-2 -- therapeutic use
- Lymphoma, B-Cell -- drug therapy
- Lymphoma, Follicular -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Recombinant Fusion Proteins -- therapeutic use
- Recurrence
- Rituximab
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.